Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours

被引：0
|
作者：
G Freyer
N Isambert
B You
S Zanetta
C Falandry
L Favier
V Trillet-Lenoir
S Assadourian
K Soussan-Lazard
S Ziti-Ljajic
P Fumoleau
机构：
[1] Université de Lyon,
[2] Service d’oncologie médicale,undefined
[3] Centre d’Investigation des Thérapeutiques en Oncologie et Hématologie,undefined
[4] Centre Hospitalier Lyon-Sud,undefined
[5] Centre Georges François Leclerc,undefined
[6] Centre d’Investigation Clinique Plurithématique 803 (INSERM CIC-P 803),undefined
[7] Sanofi-aventis Oncology,undefined
[8] Sanofi-aventis PK unit,undefined
来源：
British Journal of Cancer | 2012年 / 107卷
关键词：
aflibercept; VEGF trap; angiogenesis; anti-VEGF therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：598 / 603
页数：5
相关论文
共 50 条
  • [1] Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours
    Freyer, G.
    Isambert, N.
    You, B.
    Zanetta, S.
    Falandry, C.
    Favier, L.
    Trillet-Lenoir, V.
    Assadourian, S.
    Soussan-Lazard, K.
    Ziti-Ljajic, S.
    Fumoleau, P.
    BRITISH JOURNAL OF CANCER, 2012, 107 (04) : 598 - 603
  • [2] A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours
    I Diaz-Padilla
    L L Siu
    M San Pedro-Salcedo
    A R A Razak
    A D Colevas
    F A Shepherd
    N B Leighl
    J W Neal
    A Thibault
    L Liu
    J Lisano
    B Gao
    E B Lawson
    H A Wakelee
    British Journal of Cancer, 2012, 107 : 604 - 611
  • [3] A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours
    Diaz-Padilla, I.
    Siu, L. L.
    San Pedro-Salcedo, M.
    Razak, A. R. A.
    Colevas, A. D.
    Shepherd, F. A.
    Leighl, N. B.
    Neal, J. W.
    Thibault, A.
    Liu, L.
    Lisano, J.
    Gao, B.
    Lawson, E. B.
    Wakelee, H. A.
    BRITISH JOURNAL OF CANCER, 2012, 107 (04) : 604 - 611
  • [4] Phase I Dose-Escalation Study of Intravenous Aflibercept in Combination with Docetaxel in Patients with Advanced Solid Tumors
    Isambert, Nicolas
    Freyer, Gilles
    Zanetta, Sylvie
    You, Benoit
    Fumoleau, Pierre
    Falandry, Claire
    Favier, Laure
    Assadourian, Sylvie
    Soussan-Lazard, Karen
    Ziti-Ljajic, Samira
    Trillet-Lenoir, Veronique
    CLINICAL CANCER RESEARCH, 2012, 18 (06) : 1743 - 1750
  • [5] Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies
    Bahleda, Rastislav
    Baker, Jackie
    Massard, Christophe
    Gadgeel, Sirish M.
    Rogers, Jane E.
    Izzedine, Hassan
    Deutsch, Eric
    Garris, Jeana L.
    Khan, Akbar
    Boelle, Emmanuelle
    Assadourian, Sylvie
    Soria, Jean-Charles
    Ajani, Jaffer A.
    ONCOLOGY, 2016, 90 (01) : 10 - 20
  • [6] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
    Robert, Francisco
    Sandler, Alan
    Schiller, Joan H.
    Liu, Glenn
    Harper, Karen
    Verkh, Lev
    Huang, Xin
    Ilagan, Jennifer
    Tye, Lesley
    Chao, Richard
    Traynor, Anne M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 669 - 680
  • [7] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
    Francisco Robert
    Alan Sandler
    Joan H. Schiller
    Glenn Liu
    Karen Harper
    Lev Verkh
    Xin Huang
    Jennifer Ilagan
    Lesley Tye
    Richard Chao
    Anne M. Traynor
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 669 - 680
  • [8] A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors
    LoRusso, Patricia M.
    Infante, Jeffrey R.
    Kim, Kevin B.
    Burris, Howard A., III
    Curt, Gregory
    Emeribe, Ugochi
    Clemett, Delyth
    Tomkinson, Helen K.
    Cohen, Roger B.
    BMC CANCER, 2017, 17
  • [9] A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with docetaxel in patients with advanced solid tumors
    Robert, F.
    Sandler, A.
    Schiller, J. H.
    Ilagan, J.
    Harper, K.
    Vermeulen, W.
    Liu, G.
    Tye, L.
    Chao, R.
    Verkh, L.
    Traynor, A.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3514S - 3515S
  • [10] A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors
    Patricia M. LoRusso
    Jeffrey R. Infante
    Kevin B. Kim
    Howard A. Burris
    Gregory Curt
    Ugochi Emeribe
    Delyth Clemett
    Helen K. Tomkinson
    Roger B. Cohen
    BMC Cancer, 17
12345